These differences were all statistically significant (P ≤ 0.01) with statistical power of 100%, 100% and 100%, respectively, which indicates that CLSTN1, CLU and NGAL could be potential biomarkers for lung adenocarcinoma. This evidence concerns the gene CLU and lung adenocarcinoma.